Apremilast Offers a Strong Oral Choice for Psoriatic Arthritis Patients
More like this
- Psoriasis Patients' Options Include Effective Oral and Injectible Drugs
- A Phase II Trial Finds Ixekizumab “Extremely Effective” and Safe for Psoriasis
- Apremilast in DMARD-Naïve Patients With Psoriatis Arthritis: PALACE 4 (Phase 3)
- First Oral Medication OK'd To Fight Psoriatic Arthritis
- The 'Heartbreak of Psoriasis' Has Met Its Match!